DRAVET SYNDROME (DS)
Clinical trials for DRAVET SYNDROME (DS) explained in plain language.
Never miss a new study
Get alerted when new DRAVET SYNDROME (DS) trials appear
Sign up with your email to follow new studies for DRAVET SYNDROME (DS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Study tests safer switch from homemade CBD to approved seizure drug
Disease control Not yet recruitingThis study looks at the best way to switch children with Dravet or Lennox-Gastaut syndrome from artisanal (non-pharmaceutical) cannabidiol to Epidiolex, an FDA-approved prescription drug for seizures. About 25 children aged 2 to 18 will gradually replace their artisanal CBD with …
Matched conditions: DRAVET SYNDROME (DS)
Phase: PHASE4 • Sponsor: Elizabeth Donner • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Wearable brain sensors aim to perfect seizure drug dosing at home
Knowledge-focused Not yet recruitingThis study tests whether a wearable home monitoring system (EEG, heart rate, breathing) helps doctors feel more confident when adjusting the dose of fenfluramine for people with Dravet or Lennox-Gastaut syndrome. Twenty patients aged 3 and up will wear the devices for 3–7 days at…
Matched conditions: DRAVET SYNDROME (DS)
Phase: NA • Sponsor: Byteflies • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC